EP3645513
BENSASEPÍNAFLEIÐUR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.6.2018EP published:
5.10.2022EP application number:
18743103.6
EP translation filed:
14.11.2022Grant published:
15.12.2022EPO information:
European Patent Register
Max expiry date:
28.6.2038Expiry date:
28.6.2026Next due date:
30.6.2026
Title in English:
BENZAZEPINE DERIVATIVESLanguage of the patent:
English
Timeline
Today
29.6.2018EP application
5.10.2022EP Publication
14.11.2022Translation submitted
15.12.2022Registration published
28.6.2026Expires
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, JP
Inventor
Name:
KAN, KeizoAddress:
Osaka-shi Osaka 540-0021, JP
Name:
TAKUWA, MasatoshiAddress:
Osaka-shi Osaka 540-0021, JP
Name:
TANAKA, HirotakaAddress:
Osaka-shi Osaka 540-0021, JP
Name:
FUJIWARA, HidetoAddress:
Osaka-shi Osaka 540-0021, JP
Name:
YAMABE, HokutoAddress:
Osaka-shi Osaka 540-0021, JP
Name:
MATSUDA, SatoshiAddress:
Osaka-shi Osaka 540-0021, JP
Name:
OHDACHI, KazuhiroAddress:
Osaka-shi Osaka 540-0021, JP
Name:
HANARI, TaikiAddress:
Osaka-shi Osaka 540-0021, JP
Name:
MENJO, YasuhiroAddress:
Osaka-shi Osaka 540-0021, JP
Name:
URUSHIMA, TatsuyaAddress:
Osaka-shi Osaka 540-0021, JP
Name:
FUJITA, ShigekazuAddress:
Osaka-shi Osaka 540-0021, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
PCT/JP2017/024211Date:
30.6.2017Country:
WO
Classification
Categories:
C07D 223/16, C07D 401/14, C07D 401/06, C07D 401/10, C07D 403/06, C07D 405/12, C07D 409/12, A61P 13/12, A61K 31/55
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 24.5.2023
Expires: 28.6.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 7.5.2024
Expires: 28.6.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 10.6.2025
Expires: 28.6.2026
Payer: Árnason Faktor ehf.